Alberta Investment Management Corp Has $22.90 Million Holdings in UnitedHealth Group Incorporated $UNH

Alberta Investment Management Corp boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 58.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 73,400 shares of the healthcare conglomerate’s stock after purchasing an additional 27,111 shares during the quarter. Alberta Investment Management Corp’s holdings in UnitedHealth Group were worth $22,899,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC grew its holdings in shares of UnitedHealth Group by 3.3% in the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after acquiring an additional 675,075 shares during the period. Nuveen LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after purchasing an additional 847,054 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 3.3%

UnitedHealth Group stock opened at $321.44 on Friday. The firm has a 50 day simple moving average of $347.65 and a 200 day simple moving average of $319.44. The firm has a market capitalization of $291.17 billion, a price-to-earnings ratio of 16.78, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the business earned $7.15 EPS. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent research reports. Piper Sandler cut their price objective on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Finally, KeyCorp lifted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.